Lv5
1310 积分 2025-04-14 加入
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
6天前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
11天前
已完结
Clinical and electrocardiographic characteristics of immune checkpoint inhibitor-related myocarditis
1个月前
已完结
The role of interleukin-2 during homeostasis and activation of the immune system
2个月前
已完结
The emerging role of anti-CD25 directed therapies as both immune modulators and targeted agents in cancer
2个月前
已完结
The immune contexture in human tumours: impact on clinical outcome
2个月前
已完结
Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
2个月前
已完结
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
2个月前
已完结
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial
2个月前
已完结
New Pathologic Classification of Lung Cancer: Relevance for Clinical Practice and Clinical Trials
2个月前
已完结
皖公网安备34019202002308
